Natramune™ (PDS - 2865®)/

NEW, branded, clinically tested ingredient!

Natramune ®

Natramune™ (PDS-2865®) is a naturally obtained hemicellulose (high molecular weight polysaccharide complex with unique mixed-linkage of structure) and fatty acid mixture in their naturally occurring ratios, which has been extracted from natural sources available from Gramineae, Poaceae, Dioscoreaceae family of plants and several species of mushrooms using a protected proprietary process.

Structure/Function Claims Are:
  • Boosts immune health
  • Promotes immune functioning
  • Strengthens immune health/immune functioning
  • Immune support formula
  • Helps to reduce inflammation
  • Inflammation support formula
  • Effective Antioxidant Defense
  • Supports Antioxidant Defense
Clinical and Market Benefits:
  • Natramune ™ has substantiated structure/function claims
  • Natramune™ is in International Patent pending status and is currently trademarked
  • Natramune™ (PDS-2865®) supplementation increases human
  • Natural killer cell responsiveness and cytotoxicity
  • Natramune ™ (PDS-2865®) significantly increases circulating lymphocyte
  • Levels in healthy subjects and those with impaired immunity
  • Natramune™ (PDS-2865®) increases the number of leukocytes,T-cells, B-cells and NK cells
  • Natramune™ (PDS-2865®) significantly increases both NK cell activity and NK
  • Cell response rate
  • Natramune™ (PDS-2865®) significantly increases phagocytotic activity of macrophages
  • Natramune™ (PDS-2865®) significantly reduces xenobiotic-induced T-cell
  • Inflammatory hyperactivation
  • Natramune™ (PDS-2865®) significantly increases NO release by macrophages
Clinical Studies in Peer-Reviewed Journals:

*See conducted clinical study on Natramune™ (PDS-2865®) at the Clinical Immunology-University of Miami School of Medicine; August 2002 to November 2002 Several of the participants were immunosuppressed either with Cancer, HIV or Hepatitis C. These patients reported improvements in areas such as general well-being, sleep, mental, physical condition and had no viral syndrome or illnesses during their supplement phase. This may be related to overall Natural Killer cell activity. Natural Killer cell activity may be a more sensitive marker than overall quantitative measurement.

*See publication in JANA (The Journal of the American Nutraceutical Association) (Pilot Study: Effect of PDS-2865 on Natural Killer Cell on Citotoxicity). The article is available from the Vol.6, No.2 Spring 2003 edition of JANA

*See conducted research study on Natramune™(PDS-2865®) at the Biological Sciences, Adelphi University; 2006-2007.

*See conducted clinical study on Natramune™ (PDS-2865®) at the Miami Seaquarium and University of California Veterinary Medicine Immunology Laboratory; 2006 to 2007. Oral administration of Natramune™ (PDS-2865®) to animals of the Cetacean Species: Effects on the Immune System.